Showing results (21-30 of 148) with videos related to
Sort By:
Pageof 15
Translational Lung Cancer Research|May 17, 2023
Significance of circulating tumor cells in lung cancer: a narrative reviewGerhard Hamilton, Barbara Rath, Sandra SticklerExpert Opinion on Drug Metabolism & Toxicology|March 4, 2015
Pharmacokinetics of crizotinib in NSCLC patientsGerhard Hamilton, Barbara Rath, Otto BurghuberJournal of Cancer|August 19, 2017
In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell LinesLukas Klameth, Barbara Rath, Gerhard HamiltonTranslational Lung Cancer Research|July 25, 2015
Chitinase-3-like-1/YKL-40 as marker of circulating tumor cellsGerhard Hamilton, Barbara Rath, Otto BurghuberCurrent Cancer Drug Targets|January 26, 2024
Bromodomain Protein-directed Agents and MYC in Small Cell Lung CancerGerhard Hamilton, Sandra Stickler, Barbara RathOncology Research|April 30, 2024
Targeting KRAS in pancreatic cancerSandra Stickler, Barbara Rath, Gerhard HamiltonOncology Reports|July 29, 2003
Effects of 1alpha,25-dihydroxy-vitamin D3 pretreatment and MAP kinase inhibitor PD 98059 on response of osteoblasts to prostate-derived osteoblastic factorsErnst Ulsperger, Gerhard Hamilton, Ulrike Olszewski, et al.Clinical Pharmacology : Advances and Applications|February 1, 2012
In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compoundsUlrike Olszewski, Thomas Tuxen Poulsen, Ernst Ulsperger, et al.Metal-Based Drugs|July 10, 2009
In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer AgentUlrike Olszewski, Florian Ach, Ernst Ulsperger, et al.Translational Lung Cancer Research|March 10, 2016
Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cellsGerhard Hamilton, Barbara Rath, Sophia Holzer, et al.Pageof 15